Melvin Chua/X
Nov 2, 2024, 03:04
Melvin LK Chua: Potential Increased Risks of Toxicities with Combo IO Immunotherapy and RT
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at National Cancer Centre Singapore, shared on X:
“Thanks to ESTRO for the opportunity to speak at ESTRO Asia 24 on potential increased risks of toxicities with combo IO immunotherapy and RT. Current data suggest NO, but sequencing and tissue microenvironment may play a role.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:14
Nov 14, 2024, 16:29
Nov 14, 2024, 16:27
Nov 14, 2024, 16:22
Nov 14, 2024, 16:22
Nov 14, 2024, 16:13
Nov 14, 2024, 16:03
Nov 14, 2024, 15:58
Nov 14, 2024, 15:54